The Emerging Role of Immunotherapy for Triple-Negative Breast Cancer

The University of Chicago

Department of Medicine

 

 

Virtual Grand Rounds

 

Rita Nanda, MD

Associate Professor of Medicine

Director of Breast Oncology

Section of Hematology/Oncology

 

“The Emerging Role of Immunotherapy for Triple-Negative Breast Cancer”

Learning objectives: To define the role of immune checkpoint inhibitors in advanced and early-stage triple-negative breast cancer.

To describe immune-related adverse events associated with immune checkpoint inhibitor therapy in early stage breast cancer.

Contact Shanda Lentz for Zoom link.